What is Health Tech PR?

Health Tech PR covers communications strategy for digital health companies, telemedicine platforms, healthcare AI, medical devices, diagnostic tools, EHR vendors, payer technology, digital therapeutics, remote patient monitoring, and the broader HealthIT category. The audiences are simultaneously consumer (patients shopping for a service), professional (clinicians evaluating a tool), and institutional (health systems, payers, employers, and regulators making procurement and policy decisions). Effective health tech communications has to thread all three without overpromising clinical outcomes or running afoul of FDA labeling, HIPAA disclosure, or state corporate-practice-of-medicine rules.

The press pool itself splits across at least four ecosystems: consumer health and wellness press (Wall Street Journal Health, NPR Health, the lifestyle desks of major outlets), clinical and medical trade press (Modern Healthcare, Becker's, Fierce Healthcare, MedCity News, HealthIT News), biopharma and life sciences press (STAT News, Endpoints, Fierce Biotech), and the financial press covering public and pre-IPO health tech companies. A program that targets only one of these registers will reach only one of the audiences that decide health tech outcomes — and the audience that gets reached is rarely the one that drives the most revenue.

Why this category matters now

Three trends are concentrating budget into health tech communications right now.

First, the GLP-1 drug class (Ozempic, Wegovy, Mounjaro, Zepbound) has created a category-defining narrative shift across consumer health, prescription marketing, digital pharmacies, and adjacent wellness categories — and every adjacent company is repositioning around it, including weight management apps, nutrition platforms, employer benefits providers, and obesity care services. Hims & Hers launched its GLP-1 program in 2024 and made the regulatory and consumer-press navigation visible in real time.

Second, AI in clinical workflows has moved from pilot to procurement, and health systems now expect vendor communications to address algorithmic transparency, bias testing, training data provenance, and clinical validation explicitly. The market for ambient documentation, clinical decision support, imaging AI, and revenue-cycle automation is real and growing, and the buyers (CMIOs, CIOs, chief AI officers at health systems) are sophisticated. Tempus AI's IPO in 2024 and the broader clinical-AI category expansion are the clearest signals of where institutional budget is moving.

Third, the FDA continues to expand its digital health guidance, including software as a medical device (SaMD), clinical decision support criteria, AI/ML-enabled medical devices, and the predetermined change control plan framework — which means launch communications now need regulatory review baked in, not bolted on. State telehealth licensure rules have also tightened in several markets after the post-pandemic policy expansion, adding another layer of compliance to consumer-facing programs.

Core communications challenges

The defining challenge in health tech communications is that the most compelling story — patient outcomes — is also the most regulated. Patient testimonials require informed consent, careful framing, and FTC-compliant disclosures. Clinical claims require substantiation that holds up to FDA scrutiny. Investor communications require Reg FD-aware coordination if the company is public or pre-IPO. And HIPAA shapes everything: anything that can be construed as protected health information needs deidentification, consent, or a different framing entirely. Health tech companies that treat compliance as the comms team's job and clinical credibility as marketing's job will fail at both.

A second challenge is sales-cycle alignment: health system and payer procurement runs on long, committee-driven cycles, and PR programs that generate consumer-press hits without supporting institutional credibility produce visibility that doesn't close deals. A third challenge is the credibility hierarchy itself: peer-reviewed research outranks white papers, white papers outrank case studies, case studies outrank testimonials, and testimonials outrank executive-quote press releases. Companies that try to skip levels of the hierarchy get treated accordingly by the audiences that matter most.

What separates the strongest health tech communications programs

The strongest health tech communications programs share a few features:

• They co-locate medical, regulatory, and communications review so claims get vetted in days, not weeks.
• They build relationships with both consumer health press and clinical trade press, with separate angles, separate cadences, and separate spokespeople where appropriate.
• They publish original data, peer-reviewed where possible, because health buyers (especially institutional ones) discount marketing claims that aren't backed by evidence.
• They invest in conference presence and program at HIMSS, HLTH, ViVE, JPMorgan Healthcare Conference, and the relevant clinical society meetings.
• They develop credible physician and clinician advocates rather than relying on executives alone.
• They treat analyst relations (KLAS, Gartner, Forrester, Chilmark, Frost & Sullivan) as a multi-year program rather than a quarterly campaign.
• They build communications functions that can operate in both consumer and institutional registers without code-switching badly between them.

Brand examples across the category

The communications playbooks differ meaningfully across sub-categories:

Consumer DTC telehealth — Hims & Hers and Ro both navigate the same regulatory frame (state telehealth licensure, FDA prescription marketing, FTC substantiation) but with different brand voices. Hims runs at consumer-marketing scale with public-company financial-press discipline. Ro operates with clinical-care positioning and a more bounded consumer footprint. Both face the GLP-1 narrative restructure simultaneously.

Mental health platforms — Calm and Headspace operate as consumer mindfulness brands with carefully bounded clinical-claim language. BetterHelp (Teladoc) and Talkspace operate as clinical online-therapy platforms with provider networks and HIPAA-grade infrastructure. The communications register differs accordingly — mindfulness brands work in lifestyle and wellness press; therapy platforms work in clinical and health-policy press.

Performance wearables — Whoop and Oura both carefully navigate the wellness-versus-medical-device line. Neither makes diagnostic claims that would invite FDA classification. Both invest heavily in earned media around recovery, sleep, and performance — categories where the wellness positioning is durable.

Clinical AI — Tempus AI, Hinge Health (musculoskeletal), Maven Clinic (women's health), and the broader clinical-AI category face the most demanding evidence requirements. Peer-reviewed publication, validated clinical endpoints, and FDA SaMD pathway navigation are operating requirements, not communications nice-to-haves.

Crisis dynamics in this category

Health tech crises sit at the most regulated end of crisis communications. Data breaches trigger HIPAA notification clocks (typically 60 days for affected individuals, with state-law overlays), HHS Office for Civil Rights enforcement, and patient-trust damage that compounds with each incident. Adverse events trigger FDA reporting through MAUDE and other channels. Algorithmic errors in AI-enabled tools attract regulator attention faster than they used to, and the comms response now has to address bias, validation, and remediation specifically. Recall communications for medical devices follow Class I/II/III FDA classifications with different urgency and consumer-facing requirements.

The playbook for breach response, recall communications, FDA warning letter response, clinical-incident handling, and the emerging category of AI-incident communications is increasingly specialized — and the gap between programs that operate fluently in the category and programs that don't is widest exactly when the stakes are highest.

State of the category

The health tech communications category is more crowded than it appears, and most communications programs work in a narrow slice — consumer wellness, B2B SaaS for clinicians, medical device launches, biopharma, or digital therapeutics. The strongest programs combine regulatory literacy, clinical depth, conference and analyst infrastructure, and consumer-press capability.

Buyers evaluating health tech communications partners — internal or external — should test for three things: regulatory literacy (can the team read an FDA guidance document, and have they done so in the last 60 days), clinical depth (do they understand how providers actually evaluate tools, and have they staffed clinicians or clinical advisors), and ability to operate in both consumer and institutional registers. Programs that only know one register will deliver only half the work a serious health tech company needs.

Proprietary research

Everything-PR publishes the AI Visibility Index franchise covering Health & Wellness — ranking the brands AI engines surface in consumer health discovery against the brands that lose ground at the answer-engine layer.

Featured research: The Health & Wellness AI Visibility Index 2026 — ten brands across telehealth, supplements, mental health, and wearables ranked on the six-signal Citation Share methodology. Calm leads at composite 92, AG1 second at 90, Headspace third at 88.